RxDoctor Payments DataLook up a doctor →

Wilson Cook, MD

Family Medicine · Fredericksburg, VANPI 1326002775

Payments from drug & device makers

$17,378in general payments, 2019–2025

Across 1,180 payments — averaging $14.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Pfizer$2K
  • Novo Nordisk$1K
  • AstraZeneca$1K
  • Lilly USA, LLC$1K
  • Amgen$920
  • plus $8K from 50 others

What the payments were for

  • Food & beverage$17,17599%
  • Education$2021%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)301$2,714
Pfizer125$1,552
Novo Nordisk77$1,444
AstraZeneca70$1,379
Lilly USA, LLC63$1,017
Amgen(2 entities)61$920
GSK61$865
Astellas Pharma US Inc32$727
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC55$645
Boehringer Ingelheim33$605
Abbott22$417
Novartis24$398
Esperion Therapeutics, Inc.17$328
Merck27$315
Exact Sciences11$310
Bayer15$306
Otsuka America Pharmaceutical, Inc.17$280
Amarin Pharma, Inc.16$246
Takeda Pharmaceuticals U.S.A., Inc.14$230
Biohaven Pharmaceutical Holding Company Ltd.17$229
Lundbeck LLC10$211
Sumitomo Pharma America, Inc.8$186
Vanda Pharmaceuticals Inc.6$161
Sunovion Pharmaceuticals Inc.9$151
E.r. Squibb & Sons, L.L.C.9$136
Sanofi-aventis U.S. LLC3$132
Kowa Pharmaceuticals America, Inc.6$111
Johnson & Johnson6$105
Axsome Therapeutics, Inc.5$94
Inspire Medical Systems, Inc.1$89
Teva Pharmaceuticals USA, Inc.5$89
Dexcom, Inc.4$80
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)5$77
Boston Scientific3$70
Xeris Pharmaceuticals, Inc.3$68
Daiichi Sankyo Inc.3$55
Mylan Specialty L.p.3$54
Medtronic(2 entities)4$52
Biohaven Pharmaceuticals, Inc.3$50
Sanofi Pasteur Inc.3$48
Actelion Pharmaceuticals US, Inc.2$43
Eisai Inc.2$41
Clarus Therapeutics Inc.3$41
Philips North America LLC2$38
Dynavax Technologies Corporation1$33
Genentech USA, Inc.2$32
Alk-abello, Inc1$31
Ultragenyx Pharmaceutical Inc.2$29
Amneal Pharmaceuticals LLC1$28
Supernus Pharmaceuticals, Inc.1$23
Baxter Healthcare1$20
Seqirus USA Inc1$17
Edwards Lifesciences1$16
Tolmar, Inc.1$15
Ironwood Pharmaceuticals, Inc1$14
Ardelyx, Inc.1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$17,378 in reported general payments places this provider in the 95th percentile of 2,553 family medicine providers in Virginia.

See all family medicine providers in Virginia

Medicare billing

Part B allowed, 2024
$178,415
Medicare patients
538
Services billed
1,658

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban150$156,118
JanuviaSitagliptin Phosphate125$107,013
FarxigaDapagliflozin Propanediol116$95,550
JardianceEmpagliflozin67$89,022
OzempicSemaglutide50$70,060
MounjaroTirzepatide46$68,664
TrulicityDulaglutide37$51,938
XareltoRivaroxaban49$43,758
RybelsusSemaglutide19$28,096
Nurtec OdtRimegepant Sulfate14$24,917
Trelegy ElliptaFluticasone/Umeclidin/Vilanter28$23,889
LinzessLinaclotide31$22,839
MyrbetriqMirabegron25$22,303
Breztri AerosphereBudesonide/Glycopyr/Formoterol16$17,813
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog22$13,398

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Nurtec Odt, Premarin$1,552$189,696180 claims
Lilly USA, LLCMounjaro, Trulicity$1,017$120,60183 claims
AstraZenecaFarxiga, Breztri Aerosphere$1,379$113,363132 claims
MerckJanuvia$315$107,013125 claims
Boehringer IngelheimJardiance, Tradjenta$605$98,53182 claims
Novo NordiskOzempic, Rybelsus$1,444$98,15769 claims
Johnson & JohnsonXarelto$105$43,75849 claims
AbbVieLinzess, Synthroid$2,714$25,09085 claims
GSKTrelegy Ellipta$865$23,88928 claims
Astellas Pharma US IncMyrbetriq$727$22,30325 claims
NovartisEntresto$398$10,75315 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$28$4,554394 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,553 family medicine providers in Virginia.

Other family medicine in Fredericksburg

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →